A UHPLC-UV Method to Quantify Skin Deposition and Transdermal Permeation of Tizanidine Hydrochloride.

Tizanidine hydrochloride is an α2-adrenergic agonist used for the symptomatic relief of spasticity associated with multiple sclerosis or with spinal cord injury or disease. The objective of this study was to develop an isocratic, robust and sensitive ultra-high performance liquid chromatography method using UV detection for use in a project to develop a transdermal therapeutic system to deliver tizanidine across the skin. Isocratic separation was achieved using a C18 column and a mobile phase comprising a 80:20 mixture of 0.004% trifluoroacetic acid in water and MeCN (pH* 3.2) at a flow rate of 0.2 mL min(-1) Tizanidine eluted at 1.499 min and the total run time was 2 min. The method was specific, robust and the response was accurate, precise and linear from 17.4 to 290 ng mL(-1) In contrast to existing methods, the method developed here was validated over a concentration range so as to include the low concentrations frequently observed in transdermal permeation studies and in samples extracted from the cutaneous matrix. Its suitability for use in transdermal permeation studies was subsequently tested and confirmed in preliminary experiments using porcine skin in vitro.

[1]  Phillip Borman,et al.  Q2(R1) Validation of Analytical Procedures , 2017 .

[2]  Y. Kalia,et al.  Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  M. Walash,et al.  Spectrophotometric determination of tizanidine and orphenadrine via ion pair complex formation using eosin Y , 2011, Chemistry Central journal.

[4]  Y. Kalia,et al.  Development and validation of a rapid high-performance liquid chromatography method for the quantification of exenatide. , 2011, Biomedical chromatography : BMC.

[5]  Anil Gupta,et al.  Aceclofenac–tizanidine in the treatment of acute low back pain: a double-blind, double-dummy, randomized, multicentric, comparative study against aceclofenac alone , 2009, European Spine Journal.

[6]  S. Surana,et al.  RP-HPLC estimation of tizanidine HCl and valdecoxib in combined dosage forms , 2006 .

[7]  N. Kaul,et al.  Application of HPLC and HPTLC for the simultaneous determination of tizanidine and rofecoxib in pharmaceutical dosage form. , 2005, Journal of pharmaceutical and biomedical analysis.

[8]  M. Gandhimathi,et al.  Simultaneous LC determination of tizanidine and rofecoxib in tablets. , 2005, Journal of pharmaceutical and biomedical analysis.

[9]  P. Lillsunde,et al.  Validated semiquantitative/quantitative screening of 51 drugs in whole blood as silylated derivatives by gas chromatography-selected ion monitoring mass spectrometry and gas chromatography electron capture detection. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  K. Mahadik,et al.  Stability-indicating HPTLC determination of tizanidine hydrochloride in bulk drug and pharmaceutical formulations. , 2003, Journal of pharmaceutical and biomedical analysis.

[11]  M. Qi,et al.  Validated liquid chromatography method for assay of tizanidine in drug substance and formulated products , 2003 .

[12]  J. Seo,et al.  Determination of tizanidine in human plasma by gas chromatography-mass spectrometry. , 2002, The Analyst.

[13]  Howard S. Smith,et al.  Tizanidine in the management of spasticity and musculoskeletal complaints in the palliative care population , 2000, The American journal of hospice & palliative care.

[14]  Dennis R. Jenke,et al.  Chromatographic Method Validation: A Review of Current Practices and Procedures. I. General Concepts and Guidelines , 1996 .

[15]  D. Jenke.  Chromatographic Method Validation: A Review of Current Practices and Procedures. II. Guidelines for Primary Validation Parameters. , 1996 .

[16]  J. Kauffmann,et al.  Electrochemical behaviour of tizanidine at solid electrodes. , 1992, Journal of pharmaceutical and biomedical analysis.

[17]  H. Berry,et al.  Tizanidine and Ibuprofen in Acute Low-Back Pain: Results of a Double-Blind Multicentre Study in General Practice , 1988, The Journal of international medical research.

[18]  Faiza Qureshi,et al.  Development and validation of stability-indicating HPLC method for the simultaneous determination of paracetamol, tizanidine, and diclofenac in pharmaceuticals and human serum. , 2011, Journal of AOAC International.

[19]  S. Mutalik,et al.  A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride. , 2009, Drug delivery.